Investor Markey John
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Markey John . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2024-01-02 13G/A SONN / Sonnet BioTherapeutics Holdings, Inc. 231,115 198,300
2024-01-02 13G/A SONN / Sonnet BioTherapeutics Holdings, Inc. 231,115 198,300
2023-11-17 13G/A SONN / Sonnet BioTherapeutics Holdings, Inc. 195,780 231,115
2023-11-06 13G/A SONN / Sonnet BioTherapeutics Holdings, Inc. 195,780
2023-08-07 13G/A US83548R2040 / Sonnet BioTherapeutics Holdings, Inc. 3,700,000 4,100,000
2023-07-17 13G/A US83548R2040 / Sonnet BioTherapeutics Holdings, Inc. 3,305,000 3,700,000
2023-07-07 13G/A US83548R2040 / Sonnet BioTherapeutics Holdings, Inc. 2,830,000 3,305,000
2023-06-30 13G US83548R2040 / Sonnet BioTherapeutics Holdings, Inc. 2,720,000 2,830,000
2023-06-22 13G US89853L2034 / T2 Biosystems Inc 4,300,000 0
2023-06-16 13G US89853L2034 / T2 Biosystems Inc 3,650,000 4,300,000
2023-06-14 13G US89853L2034 / T2 Biosystems Inc 2,465,000 3,650,000
2023-06-12 13G US89853L2034 / T2 Biosystems Inc 2,465,000
2023-06-12 13G US83548R2040 / Sonnet BioTherapeutics Holdings, Inc. 2,300,000 2,720,000
2023-05-26 13G/A CELZ / Creative Medical Technology Holdings, Inc. 717,570 0
2023-05-26 13G/A US83548R2040 / Sonnet BioTherapeutics Holdings, Inc. 1,880,839 2,300,000
2023-05-17 13G/A US83548R2040 / Sonnet BioTherapeutics Holdings, Inc. 1,320,507 1,880,839
2023-05-02 13G CELZ / Creative Medical Technology Holdings, Inc. 717,570
2023-05-02 13G US83548R2040 / Sonnet BioTherapeutics Holdings, Inc. 1,320,507
2023-03-13 13G EDBL / Edible Garden AG Incorporated 120,000
2022-12-27 13G/A VLON / Vallon Pharmaceuticals Inc 849,489 0
2022-09-29 13G VLON / Vallon Pharmaceuticals Inc 849,489 849,489